Cargando…

Customized middleware experience in a tertiary care hospital hematology laboratory

BACKGROUND: In the clinical laboratory, middleware is a software application that sits between the analyzer and the laboratory information system (LIS). One of the more common uses of middleware is to perform more efficient result autoverification than can be achieved by the LIS or analyzer alone. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Roland, Kristine, Yakimec, Jim, Markin, Todd, Chan, Geoffrey, Hudoba, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577123/
https://www.ncbi.nlm.nih.gov/pubmed/36268082
http://dx.doi.org/10.1016/j.jpi.2022.100143
_version_ 1784811687332806656
author Roland, Kristine
Yakimec, Jim
Markin, Todd
Chan, Geoffrey
Hudoba, Monika
author_facet Roland, Kristine
Yakimec, Jim
Markin, Todd
Chan, Geoffrey
Hudoba, Monika
author_sort Roland, Kristine
collection PubMed
description BACKGROUND: In the clinical laboratory, middleware is a software application that sits between the analyzer and the laboratory information system (LIS). One of the more common uses of middleware is to perform more efficient result autoverification than can be achieved by the LIS or analyzer alone. In addition to autoverification, middleware can support highly customized rules to handle samples and results from specific patient locations. The objective of this study was to review the impact of customized middleware rules that were designed and implemented in the hematology laboratory of a 1000-bed tertiary care adult academic center hospital. METHODS: Three novel initiatives using middleware rules to achieve workflow efficiencies were retrospectively reviewed over different audit periods: preliminary neutrophil resulting for oncology patients, microcytosis interpretive comments, and 1 white blood cell differential (WBCD) reported per day. In addition, autoverification rates for complete blood count and differential (CBCD) and coagulation tests were calculated. RESULTS: A preliminary neutrophil count was released from middleware on average 64 min before the final CBCD for Leukemia/Bone Marrow Transplant (L/BMT) outpatients, and on average 59 min earlier for oncology patients. Reflexing interpretive comments for select instances of microcytosis removed on average 500 slides per month from technologist review with an estimated cost savings of approximately $3383.33 CAD per month. The 1 WBCD per day rule resulted in a 5.1% cancelation rate, resulting in an estimated monthly cost savings of $943.46 CAD in reagents and technologist time. Finally, middleware rules achieved very high autoverification rates of 97.2% and 88.3% for CBC and CBCD results, respectively. CONCLUSIONS: Implementation of customized middleware hematology rules in our institution resulted in multiple positive impacts on workflow, achieving high autoverification rates, reduced slide reviews, cost savings, and improved standardization.
format Online
Article
Text
id pubmed-9577123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95771232022-10-19 Customized middleware experience in a tertiary care hospital hematology laboratory Roland, Kristine Yakimec, Jim Markin, Todd Chan, Geoffrey Hudoba, Monika J Pathol Inform Original Research Article BACKGROUND: In the clinical laboratory, middleware is a software application that sits between the analyzer and the laboratory information system (LIS). One of the more common uses of middleware is to perform more efficient result autoverification than can be achieved by the LIS or analyzer alone. In addition to autoverification, middleware can support highly customized rules to handle samples and results from specific patient locations. The objective of this study was to review the impact of customized middleware rules that were designed and implemented in the hematology laboratory of a 1000-bed tertiary care adult academic center hospital. METHODS: Three novel initiatives using middleware rules to achieve workflow efficiencies were retrospectively reviewed over different audit periods: preliminary neutrophil resulting for oncology patients, microcytosis interpretive comments, and 1 white blood cell differential (WBCD) reported per day. In addition, autoverification rates for complete blood count and differential (CBCD) and coagulation tests were calculated. RESULTS: A preliminary neutrophil count was released from middleware on average 64 min before the final CBCD for Leukemia/Bone Marrow Transplant (L/BMT) outpatients, and on average 59 min earlier for oncology patients. Reflexing interpretive comments for select instances of microcytosis removed on average 500 slides per month from technologist review with an estimated cost savings of approximately $3383.33 CAD per month. The 1 WBCD per day rule resulted in a 5.1% cancelation rate, resulting in an estimated monthly cost savings of $943.46 CAD in reagents and technologist time. Finally, middleware rules achieved very high autoverification rates of 97.2% and 88.3% for CBC and CBCD results, respectively. CONCLUSIONS: Implementation of customized middleware hematology rules in our institution resulted in multiple positive impacts on workflow, achieving high autoverification rates, reduced slide reviews, cost savings, and improved standardization. Elsevier 2022-09-24 /pmc/articles/PMC9577123/ /pubmed/36268082 http://dx.doi.org/10.1016/j.jpi.2022.100143 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research Article
Roland, Kristine
Yakimec, Jim
Markin, Todd
Chan, Geoffrey
Hudoba, Monika
Customized middleware experience in a tertiary care hospital hematology laboratory
title Customized middleware experience in a tertiary care hospital hematology laboratory
title_full Customized middleware experience in a tertiary care hospital hematology laboratory
title_fullStr Customized middleware experience in a tertiary care hospital hematology laboratory
title_full_unstemmed Customized middleware experience in a tertiary care hospital hematology laboratory
title_short Customized middleware experience in a tertiary care hospital hematology laboratory
title_sort customized middleware experience in a tertiary care hospital hematology laboratory
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577123/
https://www.ncbi.nlm.nih.gov/pubmed/36268082
http://dx.doi.org/10.1016/j.jpi.2022.100143
work_keys_str_mv AT rolandkristine customizedmiddlewareexperienceinatertiarycarehospitalhematologylaboratory
AT yakimecjim customizedmiddlewareexperienceinatertiarycarehospitalhematologylaboratory
AT markintodd customizedmiddlewareexperienceinatertiarycarehospitalhematologylaboratory
AT changeoffrey customizedmiddlewareexperienceinatertiarycarehospitalhematologylaboratory
AT hudobamonika customizedmiddlewareexperienceinatertiarycarehospitalhematologylaboratory